nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—urinary bladder cancer	0.353	1	CiPCiCtD
Gemcitabine—kidney cancer—urinary bladder cancer	0.204	1	CtDrD
Gemcitabine—RRM2—urinary bladder cancer	0.131	0.68	CbGaD
Gemcitabine—TYMS—urinary bladder cancer	0.0616	0.32	CbGaD
Gemcitabine—SLC29A1—Fluorouracil—urinary bladder cancer	0.0301	0.226	CbGbCtD
Gemcitabine—TYMS—Fluorouracil—urinary bladder cancer	0.0279	0.21	CbGbCtD
Gemcitabine—ABCC10—Etoposide—urinary bladder cancer	0.0192	0.144	CbGbCtD
Gemcitabine—TYMS—Methotrexate—urinary bladder cancer	0.0154	0.116	CbGbCtD
Gemcitabine—ABCC10—Doxorubicin—urinary bladder cancer	0.0131	0.0984	CbGbCtD
Gemcitabine—ABCC10—Methotrexate—urinary bladder cancer	0.0127	0.0953	CbGbCtD
Gemcitabine—ABCB1—Mitomycin—urinary bladder cancer	0.0087	0.0654	CbGbCtD
Gemcitabine—ABCB1—Cisplatin—urinary bladder cancer	0.00182	0.0137	CbGbCtD
Gemcitabine—ABCB1—Etoposide—urinary bladder cancer	0.00179	0.0134	CbGbCtD
Gemcitabine—ABCB1—Doxorubicin—urinary bladder cancer	0.00122	0.00917	CbGbCtD
Gemcitabine—ABCB1—Methotrexate—urinary bladder cancer	0.00118	0.00888	CbGbCtD
Gemcitabine—Cytarabine—POLB—urinary bladder cancer	0.00107	1	CrCbGaD
Gemcitabine—SLC28A1—renal system—urinary bladder cancer	0.000836	0.0372	CbGeAlD
Gemcitabine—POLD1—prostate gland—urinary bladder cancer	0.000817	0.0364	CbGeAlD
Gemcitabine—SLC28A3—prostate gland—urinary bladder cancer	0.00075	0.0334	CbGeAlD
Gemcitabine—CDA—prostate gland—urinary bladder cancer	0.000734	0.0326	CbGeAlD
Gemcitabine—SLC29A2—prostate gland—urinary bladder cancer	0.000686	0.0305	CbGeAlD
Gemcitabine—CMPK1—prostate gland—urinary bladder cancer	0.000652	0.029	CbGeAlD
Gemcitabine—POLE—prostate gland—urinary bladder cancer	0.000611	0.0272	CbGeAlD
Gemcitabine—POLD1—renal system—urinary bladder cancer	0.000557	0.0248	CbGeAlD
Gemcitabine—POLA1—prostate gland—urinary bladder cancer	0.000527	0.0234	CbGeAlD
Gemcitabine—POLE—seminal vesicle—urinary bladder cancer	0.000517	0.023	CbGeAlD
Gemcitabine—RRM2—prostate gland—urinary bladder cancer	0.000503	0.0224	CbGeAlD
Gemcitabine—CMPK1—smooth muscle tissue—urinary bladder cancer	0.000462	0.0205	CbGeAlD
Gemcitabine—POLD1—female reproductive system—urinary bladder cancer	0.000446	0.0199	CbGeAlD
Gemcitabine—POLA1—seminal vesicle—urinary bladder cancer	0.000446	0.0198	CbGeAlD
Gemcitabine—CMPK1—renal system—urinary bladder cancer	0.000445	0.0198	CbGeAlD
Gemcitabine—RRM1—prostate gland—urinary bladder cancer	0.000418	0.0186	CbGeAlD
Gemcitabine—POLE—urethra—urinary bladder cancer	0.000409	0.0182	CbGeAlD
Gemcitabine—TYMS—prostate gland—urinary bladder cancer	0.000379	0.0169	CbGeAlD
Gemcitabine—SLC29A2—female reproductive system—urinary bladder cancer	0.000374	0.0167	CbGeAlD
Gemcitabine—CDA—vagina—urinary bladder cancer	0.000362	0.0161	CbGeAlD
Gemcitabine—CMPK1—female reproductive system—urinary bladder cancer	0.000356	0.0158	CbGeAlD
Gemcitabine—RRM1—seminal vesicle—urinary bladder cancer	0.000354	0.0157	CbGeAlD
Gemcitabine—POLA1—urethra—urinary bladder cancer	0.000353	0.0157	CbGeAlD
Gemcitabine—RRM2—renal system—urinary bladder cancer	0.000343	0.0153	CbGeAlD
Gemcitabine—SLC29A1—prostate gland—urinary bladder cancer	0.00034	0.0151	CbGeAlD
Gemcitabine—SLC29A2—vagina—urinary bladder cancer	0.000339	0.0151	CbGeAlD
Gemcitabine—POLE—female reproductive system—urinary bladder cancer	0.000334	0.0148	CbGeAlD
Gemcitabine—DCK—prostate gland—urinary bladder cancer	0.000325	0.0144	CbGeAlD
Gemcitabine—CMPK1—vagina—urinary bladder cancer	0.000322	0.0143	CbGeAlD
Gemcitabine—ABCC10—prostate gland—urinary bladder cancer	0.000309	0.0138	CbGeAlD
Gemcitabine—POLE—vagina—urinary bladder cancer	0.000302	0.0134	CbGeAlD
Gemcitabine—RRM1—smooth muscle tissue—urinary bladder cancer	0.000296	0.0132	CbGeAlD
Gemcitabine—RRM1—renal system—urinary bladder cancer	0.000285	0.0127	CbGeAlD
Gemcitabine—RRM1—urethra—urinary bladder cancer	0.00028	0.0125	CbGeAlD
Gemcitabine—RRM2—female reproductive system—urinary bladder cancer	0.000275	0.0122	CbGeAlD
Gemcitabine—DCK—seminal vesicle—urinary bladder cancer	0.000275	0.0122	CbGeAlD
Gemcitabine—TYMS—smooth muscle tissue—urinary bladder cancer	0.000268	0.0119	CbGeAlD
Gemcitabine—ABCC10—seminal vesicle—urinary bladder cancer	0.000262	0.0116	CbGeAlD
Gemcitabine—POLD1—lymph node—urinary bladder cancer	0.000261	0.0116	CbGeAlD
Gemcitabine—POLA1—vagina—urinary bladder cancer	0.00026	0.0116	CbGeAlD
Gemcitabine—DCK—Epirubicin—Valrubicin—urinary bladder cancer	0.000251	0.315	CbGdCrCtD
Gemcitabine—DCK—Doxorubicin—Valrubicin—urinary bladder cancer	0.000251	0.315	CbGdCrCtD
Gemcitabine—RRM2—vagina—urinary bladder cancer	0.000248	0.0111	CbGeAlD
Gemcitabine—CDA—lymph node—urinary bladder cancer	0.000234	0.0104	CbGeAlD
Gemcitabine—SLC29A1—renal system—urinary bladder cancer	0.000232	0.0103	CbGeAlD
Gemcitabine—RRM1—female reproductive system—urinary bladder cancer	0.000228	0.0102	CbGeAlD
Gemcitabine—SLC29A1—urethra—urinary bladder cancer	0.000228	0.0101	CbGeAlD
Gemcitabine—SLC29A2—lymph node—urinary bladder cancer	0.000219	0.00974	CbGeAlD
Gemcitabine—DCK—urethra—urinary bladder cancer	0.000217	0.00967	CbGeAlD
Gemcitabine—ABCC10—renal system—urinary bladder cancer	0.000211	0.00938	CbGeAlD
Gemcitabine—CMPK1—lymph node—urinary bladder cancer	0.000208	0.00927	CbGeAlD
Gemcitabine—ABCC10—urethra—urinary bladder cancer	0.000207	0.00922	CbGeAlD
Gemcitabine—TYMS—female reproductive system—urinary bladder cancer	0.000207	0.00921	CbGeAlD
Gemcitabine—RRM1—vagina—urinary bladder cancer	0.000206	0.00918	CbGeAlD
Gemcitabine—POLE—lymph node—urinary bladder cancer	0.000195	0.00868	CbGeAlD
Gemcitabine—TYMS—vagina—urinary bladder cancer	0.000187	0.00833	CbGeAlD
Gemcitabine—SLC29A1—female reproductive system—urinary bladder cancer	0.000186	0.00826	CbGeAlD
Gemcitabine—DCK—female reproductive system—urinary bladder cancer	0.000177	0.00789	CbGeAlD
Gemcitabine—ABCC10—female reproductive system—urinary bladder cancer	0.000169	0.00751	CbGeAlD
Gemcitabine—POLA1—lymph node—urinary bladder cancer	0.000168	0.00748	CbGeAlD
Gemcitabine—SLC29A1—vagina—urinary bladder cancer	0.000168	0.00747	CbGeAlD
Gemcitabine—RRM2—lymph node—urinary bladder cancer	0.000161	0.00715	CbGeAlD
Gemcitabine—DCK—vagina—urinary bladder cancer	0.00016	0.00713	CbGeAlD
Gemcitabine—ABCC10—vagina—urinary bladder cancer	0.000153	0.0068	CbGeAlD
Gemcitabine—RRM1—lymph node—urinary bladder cancer	0.000134	0.00594	CbGeAlD
Gemcitabine—TYMS—Podofilox—Etoposide—urinary bladder cancer	0.000126	0.158	CbGdCrCtD
Gemcitabine—TYMS—lymph node—urinary bladder cancer	0.000121	0.00539	CbGeAlD
Gemcitabine—SLC29A1—lymph node—urinary bladder cancer	0.000109	0.00483	CbGeAlD
Gemcitabine—DCK—lymph node—urinary bladder cancer	0.000104	0.00461	CbGeAlD
Gemcitabine—ABCC10—lymph node—urinary bladder cancer	9.88e-05	0.0044	CbGeAlD
Gemcitabine—ABCB1—prostate gland—urinary bladder cancer	8.93e-05	0.00397	CbGeAlD
Gemcitabine—DCK—Doxorubicin—Epirubicin—urinary bladder cancer	8.74e-05	0.11	CbGdCrCtD
Gemcitabine—DCK—Epirubicin—Doxorubicin—urinary bladder cancer	8.09e-05	0.101	CbGdCrCtD
Gemcitabine—ABCB1—seminal vesicle—urinary bladder cancer	7.56e-05	0.00336	CbGeAlD
Gemcitabine—ABCB1—epithelium—urinary bladder cancer	6.56e-05	0.00292	CbGeAlD
Gemcitabine—ABCB1—renal system—urinary bladder cancer	6.09e-05	0.00271	CbGeAlD
Gemcitabine—ABCB1—urethra—urinary bladder cancer	5.98e-05	0.00266	CbGeAlD
Gemcitabine—ABCB1—female reproductive system—urinary bladder cancer	4.88e-05	0.00217	CbGeAlD
Gemcitabine—ABCB1—vagina—urinary bladder cancer	4.41e-05	0.00196	CbGeAlD
Gemcitabine—ABCB1—lymph node—urinary bladder cancer	2.85e-05	0.00127	CbGeAlD
Gemcitabine—Hypokalaemia—Doxorubicin—urinary bladder cancer	2.31e-05	0.000461	CcSEcCtD
Gemcitabine—Anorexia—Etoposide—urinary bladder cancer	2.29e-05	0.000457	CcSEcCtD
Gemcitabine—Diarrhoea—Thiotepa—urinary bladder cancer	2.29e-05	0.000457	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	2.28e-05	0.000456	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	2.28e-05	0.000456	CcSEcCtD
Gemcitabine—Decreased appetite—Cisplatin—urinary bladder cancer	2.28e-05	0.000455	CcSEcCtD
Gemcitabine—Feeling abnormal—Fluorouracil—urinary bladder cancer	2.28e-05	0.000455	CcSEcCtD
Gemcitabine—Pneumonia—Methotrexate—urinary bladder cancer	2.27e-05	0.000453	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	2.26e-05	0.000452	CcSEcCtD
Gemcitabine—Pancytopenia—Epirubicin—urinary bladder cancer	2.25e-05	0.000449	CcSEcCtD
Gemcitabine—Hypotension—Etoposide—urinary bladder cancer	2.24e-05	0.000448	CcSEcCtD
Gemcitabine—Pain—Cisplatin—urinary bladder cancer	2.24e-05	0.000448	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	2.24e-05	0.000447	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	2.23e-05	0.000447	CcSEcCtD
Gemcitabine—Renal failure—Methotrexate—urinary bladder cancer	2.22e-05	0.000443	CcSEcCtD
Gemcitabine—Neutropenia—Epirubicin—urinary bladder cancer	2.21e-05	0.000442	CcSEcCtD
Gemcitabine—Stomatitis—Methotrexate—urinary bladder cancer	2.2e-05	0.000439	CcSEcCtD
Gemcitabine—Influenza—Doxorubicin—urinary bladder cancer	2.19e-05	0.000438	CcSEcCtD
Gemcitabine—Body temperature increased—Fluorouracil—urinary bladder cancer	2.19e-05	0.000437	CcSEcCtD
Gemcitabine—Sweating—Methotrexate—urinary bladder cancer	2.16e-05	0.000432	CcSEcCtD
Gemcitabine—Feeling abnormal—Cisplatin—urinary bladder cancer	2.16e-05	0.000432	CcSEcCtD
Gemcitabine—Paraesthesia—Etoposide—urinary bladder cancer	2.16e-05	0.000431	CcSEcCtD
Gemcitabine—Haematuria—Methotrexate—urinary bladder cancer	2.15e-05	0.00043	CcSEcCtD
Gemcitabine—Dyspnoea—Etoposide—urinary bladder cancer	2.14e-05	0.000428	CcSEcCtD
Gemcitabine—Hyperglycaemia—Epirubicin—urinary bladder cancer	2.13e-05	0.000427	CcSEcCtD
Gemcitabine—Somnolence—Etoposide—urinary bladder cancer	2.13e-05	0.000427	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Methotrexate—urinary bladder cancer	2.13e-05	0.000426	CcSEcCtD
Gemcitabine—Vomiting—Thiotepa—urinary bladder cancer	2.13e-05	0.000425	CcSEcCtD
Gemcitabine—Pneumonia—Epirubicin—urinary bladder cancer	2.12e-05	0.000424	CcSEcCtD
Gemcitabine—Rash—Thiotepa—urinary bladder cancer	2.11e-05	0.000421	CcSEcCtD
Gemcitabine—Dermatitis—Thiotepa—urinary bladder cancer	2.11e-05	0.000421	CcSEcCtD
Gemcitabine—Agranulocytosis—Methotrexate—urinary bladder cancer	2.1e-05	0.000421	CcSEcCtD
Gemcitabine—Headache—Thiotepa—urinary bladder cancer	2.09e-05	0.000418	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	2.09e-05	0.000418	CcSEcCtD
Gemcitabine—Decreased appetite—Etoposide—urinary bladder cancer	2.09e-05	0.000417	CcSEcCtD
Gemcitabine—Pancytopenia—Doxorubicin—urinary bladder cancer	2.08e-05	0.000416	CcSEcCtD
Gemcitabine—Renal failure—Epirubicin—urinary bladder cancer	2.07e-05	0.000415	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	2.07e-05	0.000414	CcSEcCtD
Gemcitabine—Body temperature increased—Cisplatin—urinary bladder cancer	2.07e-05	0.000414	CcSEcCtD
Gemcitabine—Fatigue—Etoposide—urinary bladder cancer	2.07e-05	0.000414	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Epirubicin—urinary bladder cancer	2.07e-05	0.000413	CcSEcCtD
Gemcitabine—Stomatitis—Epirubicin—urinary bladder cancer	2.06e-05	0.000411	CcSEcCtD
Gemcitabine—Constipation—Etoposide—urinary bladder cancer	2.05e-05	0.00041	CcSEcCtD
Gemcitabine—Pain—Etoposide—urinary bladder cancer	2.05e-05	0.00041	CcSEcCtD
Gemcitabine—Neutropenia—Doxorubicin—urinary bladder cancer	2.05e-05	0.000409	CcSEcCtD
Gemcitabine—Haemoglobin—Methotrexate—urinary bladder cancer	2.03e-05	0.000407	CcSEcCtD
Gemcitabine—Haemorrhage—Methotrexate—urinary bladder cancer	2.02e-05	0.000405	CcSEcCtD
Gemcitabine—Sweating—Epirubicin—urinary bladder cancer	2.02e-05	0.000404	CcSEcCtD
Gemcitabine—Haematuria—Epirubicin—urinary bladder cancer	2.01e-05	0.000402	CcSEcCtD
Gemcitabine—Pharyngitis—Methotrexate—urinary bladder cancer	2.01e-05	0.000401	CcSEcCtD
Gemcitabine—Urinary tract disorder—Methotrexate—urinary bladder cancer	2e-05	0.000399	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Epirubicin—urinary bladder cancer	2e-05	0.000399	CcSEcCtD
Gemcitabine—Nausea—Thiotepa—urinary bladder cancer	1.99e-05	0.000397	CcSEcCtD
Gemcitabine—Urethral disorder—Methotrexate—urinary bladder cancer	1.98e-05	0.000397	CcSEcCtD
Gemcitabine—Feeling abnormal—Etoposide—urinary bladder cancer	1.98e-05	0.000395	CcSEcCtD
Gemcitabine—Hyperglycaemia—Doxorubicin—urinary bladder cancer	1.98e-05	0.000395	CcSEcCtD
Gemcitabine—Agranulocytosis—Epirubicin—urinary bladder cancer	1.97e-05	0.000394	CcSEcCtD
Gemcitabine—Pneumonia—Doxorubicin—urinary bladder cancer	1.96e-05	0.000392	CcSEcCtD
Gemcitabine—Pruritus—Fluorouracil—urinary bladder cancer	1.96e-05	0.000391	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	1.94e-05	0.000387	CcSEcCtD
Gemcitabine—Renal failure—Doxorubicin—urinary bladder cancer	1.92e-05	0.000384	CcSEcCtD
Gemcitabine—Erythema multiforme—Methotrexate—urinary bladder cancer	1.91e-05	0.000382	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	1.91e-05	0.000382	CcSEcCtD
Gemcitabine—Haemoglobin—Epirubicin—urinary bladder cancer	1.9e-05	0.00038	CcSEcCtD
Gemcitabine—Stomatitis—Doxorubicin—urinary bladder cancer	1.9e-05	0.00038	CcSEcCtD
Gemcitabine—Rhinitis—Epirubicin—urinary bladder cancer	1.9e-05	0.00038	CcSEcCtD
Gemcitabine—Body temperature increased—Etoposide—urinary bladder cancer	1.9e-05	0.000379	CcSEcCtD
Gemcitabine—Haemorrhage—Epirubicin—urinary bladder cancer	1.89e-05	0.000379	CcSEcCtD
Gemcitabine—Diarrhoea—Fluorouracil—urinary bladder cancer	1.89e-05	0.000378	CcSEcCtD
Gemcitabine—Asthenia—Cisplatin—urinary bladder cancer	1.88e-05	0.000376	CcSEcCtD
Gemcitabine—Pharyngitis—Epirubicin—urinary bladder cancer	1.88e-05	0.000376	CcSEcCtD
Gemcitabine—Cardiac disorder—Methotrexate—urinary bladder cancer	1.88e-05	0.000375	CcSEcCtD
Gemcitabine—Sweating—Doxorubicin—urinary bladder cancer	1.87e-05	0.000374	CcSEcCtD
Gemcitabine—Urinary tract disorder—Epirubicin—urinary bladder cancer	1.87e-05	0.000374	CcSEcCtD
Gemcitabine—Oedema peripheral—Epirubicin—urinary bladder cancer	1.87e-05	0.000373	CcSEcCtD
Gemcitabine—Haematuria—Doxorubicin—urinary bladder cancer	1.86e-05	0.000372	CcSEcCtD
Gemcitabine—Connective tissue disorder—Epirubicin—urinary bladder cancer	1.86e-05	0.000372	CcSEcCtD
Gemcitabine—Urethral disorder—Epirubicin—urinary bladder cancer	1.86e-05	0.000371	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	1.85e-05	0.000369	CcSEcCtD
Gemcitabine—Angiopathy—Methotrexate—urinary bladder cancer	1.84e-05	0.000367	CcSEcCtD
Gemcitabine—Immune system disorder—Methotrexate—urinary bladder cancer	1.83e-05	0.000365	CcSEcCtD
Gemcitabine—Mediastinal disorder—Methotrexate—urinary bladder cancer	1.82e-05	0.000365	CcSEcCtD
Gemcitabine—Agranulocytosis—Doxorubicin—urinary bladder cancer	1.82e-05	0.000364	CcSEcCtD
Gemcitabine—Chills—Methotrexate—urinary bladder cancer	1.82e-05	0.000363	CcSEcCtD
Gemcitabine—Diarrhoea—Cisplatin—urinary bladder cancer	1.79e-05	0.000358	CcSEcCtD
Gemcitabine—Erythema multiforme—Epirubicin—urinary bladder cancer	1.79e-05	0.000358	CcSEcCtD
Gemcitabine—Alopecia—Methotrexate—urinary bladder cancer	1.79e-05	0.000357	CcSEcCtD
Gemcitabine—Erythema—Methotrexate—urinary bladder cancer	1.76e-05	0.000352	CcSEcCtD
Gemcitabine—Haemoglobin—Doxorubicin—urinary bladder cancer	1.76e-05	0.000352	CcSEcCtD
Gemcitabine—Cardiac disorder—Epirubicin—urinary bladder cancer	1.76e-05	0.000351	CcSEcCtD
Gemcitabine—Vomiting—Fluorouracil—urinary bladder cancer	1.76e-05	0.000351	CcSEcCtD
Gemcitabine—Rhinitis—Doxorubicin—urinary bladder cancer	1.76e-05	0.000351	CcSEcCtD
Gemcitabine—Haemorrhage—Doxorubicin—urinary bladder cancer	1.75e-05	0.00035	CcSEcCtD
Gemcitabine—Rash—Fluorouracil—urinary bladder cancer	1.74e-05	0.000348	CcSEcCtD
Gemcitabine—Dermatitis—Fluorouracil—urinary bladder cancer	1.74e-05	0.000348	CcSEcCtD
Gemcitabine—Pharyngitis—Doxorubicin—urinary bladder cancer	1.74e-05	0.000348	CcSEcCtD
Gemcitabine—Headache—Fluorouracil—urinary bladder cancer	1.73e-05	0.000346	CcSEcCtD
Gemcitabine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	1.73e-05	0.000346	CcSEcCtD
Gemcitabine—Oedema peripheral—Doxorubicin—urinary bladder cancer	1.73e-05	0.000345	CcSEcCtD
Gemcitabine—Asthenia—Etoposide—urinary bladder cancer	1.72e-05	0.000344	CcSEcCtD
Gemcitabine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	1.72e-05	0.000344	CcSEcCtD
Gemcitabine—Angiopathy—Epirubicin—urinary bladder cancer	1.72e-05	0.000343	CcSEcCtD
Gemcitabine—Urethral disorder—Doxorubicin—urinary bladder cancer	1.72e-05	0.000343	CcSEcCtD
Gemcitabine—Immune system disorder—Epirubicin—urinary bladder cancer	1.71e-05	0.000342	CcSEcCtD
Gemcitabine—Mediastinal disorder—Epirubicin—urinary bladder cancer	1.71e-05	0.000341	CcSEcCtD
Gemcitabine—Back pain—Methotrexate—urinary bladder cancer	1.7e-05	0.000341	CcSEcCtD
Gemcitabine—Chills—Epirubicin—urinary bladder cancer	1.7e-05	0.00034	CcSEcCtD
Gemcitabine—Pruritus—Etoposide—urinary bladder cancer	1.7e-05	0.000339	CcSEcCtD
Gemcitabine—Arrhythmia—Epirubicin—urinary bladder cancer	1.69e-05	0.000338	CcSEcCtD
Gemcitabine—Alopecia—Epirubicin—urinary bladder cancer	1.67e-05	0.000335	CcSEcCtD
Gemcitabine—Vomiting—Cisplatin—urinary bladder cancer	1.67e-05	0.000333	CcSEcCtD
Gemcitabine—Erythema multiforme—Doxorubicin—urinary bladder cancer	1.66e-05	0.000331	CcSEcCtD
Gemcitabine—Rash—Cisplatin—urinary bladder cancer	1.65e-05	0.00033	CcSEcCtD
Gemcitabine—Dermatitis—Cisplatin—urinary bladder cancer	1.65e-05	0.00033	CcSEcCtD
Gemcitabine—Erythema—Epirubicin—urinary bladder cancer	1.65e-05	0.00033	CcSEcCtD
Gemcitabine—Diarrhoea—Etoposide—urinary bladder cancer	1.64e-05	0.000328	CcSEcCtD
Gemcitabine—Nausea—Fluorouracil—urinary bladder cancer	1.64e-05	0.000328	CcSEcCtD
Gemcitabine—Ill-defined disorder—Methotrexate—urinary bladder cancer	1.64e-05	0.000327	CcSEcCtD
Gemcitabine—Anaemia—Methotrexate—urinary bladder cancer	1.63e-05	0.000325	CcSEcCtD
Gemcitabine—Cardiac disorder—Doxorubicin—urinary bladder cancer	1.63e-05	0.000325	CcSEcCtD
Gemcitabine—Back pain—Epirubicin—urinary bladder cancer	1.6e-05	0.000319	CcSEcCtD
Gemcitabine—Angiopathy—Doxorubicin—urinary bladder cancer	1.59e-05	0.000318	CcSEcCtD
Gemcitabine—Malaise—Methotrexate—urinary bladder cancer	1.59e-05	0.000318	CcSEcCtD
Gemcitabine—Immune system disorder—Doxorubicin—urinary bladder cancer	1.58e-05	0.000316	CcSEcCtD
Gemcitabine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	1.58e-05	0.000316	CcSEcCtD
Gemcitabine—Leukopenia—Methotrexate—urinary bladder cancer	1.58e-05	0.000315	CcSEcCtD
Gemcitabine—Chills—Doxorubicin—urinary bladder cancer	1.57e-05	0.000314	CcSEcCtD
Gemcitabine—Arrhythmia—Doxorubicin—urinary bladder cancer	1.57e-05	0.000313	CcSEcCtD
Gemcitabine—Nausea—Cisplatin—urinary bladder cancer	1.56e-05	0.000311	CcSEcCtD
Gemcitabine—Alopecia—Doxorubicin—urinary bladder cancer	1.55e-05	0.00031	CcSEcCtD
Gemcitabine—Cough—Methotrexate—urinary bladder cancer	1.54e-05	0.000307	CcSEcCtD
Gemcitabine—Ill-defined disorder—Epirubicin—urinary bladder cancer	1.53e-05	0.000306	CcSEcCtD
Gemcitabine—Vomiting—Etoposide—urinary bladder cancer	1.53e-05	0.000305	CcSEcCtD
Gemcitabine—Erythema—Doxorubicin—urinary bladder cancer	1.53e-05	0.000305	CcSEcCtD
Gemcitabine—Anaemia—Epirubicin—urinary bladder cancer	1.52e-05	0.000305	CcSEcCtD
Gemcitabine—Rash—Etoposide—urinary bladder cancer	1.51e-05	0.000303	CcSEcCtD
Gemcitabine—Dermatitis—Etoposide—urinary bladder cancer	1.51e-05	0.000302	CcSEcCtD
Gemcitabine—Headache—Etoposide—urinary bladder cancer	1.5e-05	0.000301	CcSEcCtD
Gemcitabine—Myalgia—Methotrexate—urinary bladder cancer	1.5e-05	0.0003	CcSEcCtD
Gemcitabine—Arthralgia—Methotrexate—urinary bladder cancer	1.5e-05	0.0003	CcSEcCtD
Gemcitabine—Chest pain—Methotrexate—urinary bladder cancer	1.5e-05	0.0003	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	1.49e-05	0.000298	CcSEcCtD
Gemcitabine—Malaise—Epirubicin—urinary bladder cancer	1.49e-05	0.000297	CcSEcCtD
Gemcitabine—Discomfort—Methotrexate—urinary bladder cancer	1.48e-05	0.000296	CcSEcCtD
Gemcitabine—Leukopenia—Epirubicin—urinary bladder cancer	1.48e-05	0.000295	CcSEcCtD
Gemcitabine—Back pain—Doxorubicin—urinary bladder cancer	1.48e-05	0.000295	CcSEcCtD
Gemcitabine—Cough—Epirubicin—urinary bladder cancer	1.44e-05	0.000288	CcSEcCtD
Gemcitabine—Anaphylactic shock—Methotrexate—urinary bladder cancer	1.44e-05	0.000287	CcSEcCtD
Gemcitabine—Infection—Methotrexate—urinary bladder cancer	1.43e-05	0.000286	CcSEcCtD
Gemcitabine—Nausea—Etoposide—urinary bladder cancer	1.43e-05	0.000285	CcSEcCtD
Gemcitabine—Hypertension—Epirubicin—urinary bladder cancer	1.42e-05	0.000285	CcSEcCtD
Gemcitabine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	1.42e-05	0.000283	CcSEcCtD
Gemcitabine—Nervous system disorder—Methotrexate—urinary bladder cancer	1.41e-05	0.000282	CcSEcCtD
Gemcitabine—Anaemia—Doxorubicin—urinary bladder cancer	1.41e-05	0.000282	CcSEcCtD
Gemcitabine—Thrombocytopenia—Methotrexate—urinary bladder cancer	1.41e-05	0.000281	CcSEcCtD
Gemcitabine—Chest pain—Epirubicin—urinary bladder cancer	1.4e-05	0.000281	CcSEcCtD
Gemcitabine—Myalgia—Epirubicin—urinary bladder cancer	1.4e-05	0.000281	CcSEcCtD
Gemcitabine—Arthralgia—Epirubicin—urinary bladder cancer	1.4e-05	0.000281	CcSEcCtD
Gemcitabine—Skin disorder—Methotrexate—urinary bladder cancer	1.4e-05	0.000279	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	1.39e-05	0.000279	CcSEcCtD
Gemcitabine—Hyperhidrosis—Methotrexate—urinary bladder cancer	1.39e-05	0.000278	CcSEcCtD
Gemcitabine—Discomfort—Epirubicin—urinary bladder cancer	1.39e-05	0.000277	CcSEcCtD
Gemcitabine—Malaise—Doxorubicin—urinary bladder cancer	1.38e-05	0.000275	CcSEcCtD
Gemcitabine—Anorexia—Methotrexate—urinary bladder cancer	1.37e-05	0.000274	CcSEcCtD
Gemcitabine—Leukopenia—Doxorubicin—urinary bladder cancer	1.37e-05	0.000273	CcSEcCtD
Gemcitabine—Anaphylactic shock—Epirubicin—urinary bladder cancer	1.35e-05	0.000269	CcSEcCtD
Gemcitabine—Oedema—Epirubicin—urinary bladder cancer	1.35e-05	0.000269	CcSEcCtD
Gemcitabine—Hypotension—Methotrexate—urinary bladder cancer	1.34e-05	0.000269	CcSEcCtD
Gemcitabine—Infection—Epirubicin—urinary bladder cancer	1.34e-05	0.000267	CcSEcCtD
Gemcitabine—Cough—Doxorubicin—urinary bladder cancer	1.33e-05	0.000266	CcSEcCtD
Gemcitabine—Nervous system disorder—Epirubicin—urinary bladder cancer	1.32e-05	0.000264	CcSEcCtD
Gemcitabine—Thrombocytopenia—Epirubicin—urinary bladder cancer	1.32e-05	0.000263	CcSEcCtD
Gemcitabine—Hypertension—Doxorubicin—urinary bladder cancer	1.32e-05	0.000263	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	1.31e-05	0.000262	CcSEcCtD
Gemcitabine—Skin disorder—Epirubicin—urinary bladder cancer	1.31e-05	0.000261	CcSEcCtD
Gemcitabine—Hyperhidrosis—Epirubicin—urinary bladder cancer	1.3e-05	0.00026	CcSEcCtD
Gemcitabine—Insomnia—Methotrexate—urinary bladder cancer	1.3e-05	0.00026	CcSEcCtD
Gemcitabine—Myalgia—Doxorubicin—urinary bladder cancer	1.3e-05	0.00026	CcSEcCtD
Gemcitabine—Chest pain—Doxorubicin—urinary bladder cancer	1.3e-05	0.00026	CcSEcCtD
Gemcitabine—Arthralgia—Doxorubicin—urinary bladder cancer	1.3e-05	0.00026	CcSEcCtD
Gemcitabine—Paraesthesia—Methotrexate—urinary bladder cancer	1.29e-05	0.000258	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	1.29e-05	0.000258	CcSEcCtD
Gemcitabine—Discomfort—Doxorubicin—urinary bladder cancer	1.28e-05	0.000256	CcSEcCtD
Gemcitabine—Anorexia—Epirubicin—urinary bladder cancer	1.28e-05	0.000256	CcSEcCtD
Gemcitabine—Dyspnoea—Methotrexate—urinary bladder cancer	1.28e-05	0.000256	CcSEcCtD
Gemcitabine—Somnolence—Methotrexate—urinary bladder cancer	1.28e-05	0.000255	CcSEcCtD
Gemcitabine—Hypotension—Epirubicin—urinary bladder cancer	1.26e-05	0.000251	CcSEcCtD
Gemcitabine—Decreased appetite—Methotrexate—urinary bladder cancer	1.25e-05	0.00025	CcSEcCtD
Gemcitabine—Oedema—Doxorubicin—urinary bladder cancer	1.25e-05	0.000249	CcSEcCtD
Gemcitabine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	1.25e-05	0.000249	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	1.24e-05	0.000248	CcSEcCtD
Gemcitabine—Fatigue—Methotrexate—urinary bladder cancer	1.24e-05	0.000248	CcSEcCtD
Gemcitabine—Infection—Doxorubicin—urinary bladder cancer	1.24e-05	0.000247	CcSEcCtD
Gemcitabine—Pain—Methotrexate—urinary bladder cancer	1.23e-05	0.000246	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	1.23e-05	0.000245	CcSEcCtD
Gemcitabine—Nervous system disorder—Doxorubicin—urinary bladder cancer	1.22e-05	0.000244	CcSEcCtD
Gemcitabine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	1.22e-05	0.000244	CcSEcCtD
Gemcitabine—Insomnia—Epirubicin—urinary bladder cancer	1.22e-05	0.000243	CcSEcCtD
Gemcitabine—Skin disorder—Doxorubicin—urinary bladder cancer	1.21e-05	0.000242	CcSEcCtD
Gemcitabine—Paraesthesia—Epirubicin—urinary bladder cancer	1.21e-05	0.000242	CcSEcCtD
Gemcitabine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	1.2e-05	0.000241	CcSEcCtD
Gemcitabine—Dyspnoea—Epirubicin—urinary bladder cancer	1.2e-05	0.00024	CcSEcCtD
Gemcitabine—Somnolence—Epirubicin—urinary bladder cancer	1.2e-05	0.000239	CcSEcCtD
Gemcitabine—Anorexia—Doxorubicin—urinary bladder cancer	1.19e-05	0.000237	CcSEcCtD
Gemcitabine—Feeling abnormal—Methotrexate—urinary bladder cancer	1.19e-05	0.000237	CcSEcCtD
Gemcitabine—Decreased appetite—Epirubicin—urinary bladder cancer	1.17e-05	0.000234	CcSEcCtD
Gemcitabine—Hypotension—Doxorubicin—urinary bladder cancer	1.16e-05	0.000233	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	1.16e-05	0.000232	CcSEcCtD
Gemcitabine—Fatigue—Epirubicin—urinary bladder cancer	1.16e-05	0.000232	CcSEcCtD
Gemcitabine—Pain—Epirubicin—urinary bladder cancer	1.15e-05	0.00023	CcSEcCtD
Gemcitabine—Constipation—Epirubicin—urinary bladder cancer	1.15e-05	0.00023	CcSEcCtD
Gemcitabine—Body temperature increased—Methotrexate—urinary bladder cancer	1.14e-05	0.000227	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	1.13e-05	0.000227	CcSEcCtD
Gemcitabine—Insomnia—Doxorubicin—urinary bladder cancer	1.13e-05	0.000225	CcSEcCtD
Gemcitabine—Paraesthesia—Doxorubicin—urinary bladder cancer	1.12e-05	0.000223	CcSEcCtD
Gemcitabine—Dyspnoea—Doxorubicin—urinary bladder cancer	1.11e-05	0.000222	CcSEcCtD
Gemcitabine—Feeling abnormal—Epirubicin—urinary bladder cancer	1.11e-05	0.000222	CcSEcCtD
Gemcitabine—Somnolence—Doxorubicin—urinary bladder cancer	1.11e-05	0.000221	CcSEcCtD
Gemcitabine—Decreased appetite—Doxorubicin—urinary bladder cancer	1.08e-05	0.000216	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	1.08e-05	0.000215	CcSEcCtD
Gemcitabine—Fatigue—Doxorubicin—urinary bladder cancer	1.07e-05	0.000215	CcSEcCtD
Gemcitabine—Constipation—Doxorubicin—urinary bladder cancer	1.06e-05	0.000213	CcSEcCtD
Gemcitabine—Pain—Doxorubicin—urinary bladder cancer	1.06e-05	0.000213	CcSEcCtD
Gemcitabine—Body temperature increased—Epirubicin—urinary bladder cancer	1.06e-05	0.000213	CcSEcCtD
Gemcitabine—Asthenia—Methotrexate—urinary bladder cancer	1.03e-05	0.000206	CcSEcCtD
Gemcitabine—Feeling abnormal—Doxorubicin—urinary bladder cancer	1.03e-05	0.000205	CcSEcCtD
Gemcitabine—Pruritus—Methotrexate—urinary bladder cancer	1.02e-05	0.000203	CcSEcCtD
Gemcitabine—Body temperature increased—Doxorubicin—urinary bladder cancer	9.84e-06	0.000197	CcSEcCtD
Gemcitabine—Diarrhoea—Methotrexate—urinary bladder cancer	9.84e-06	0.000197	CcSEcCtD
Gemcitabine—Asthenia—Epirubicin—urinary bladder cancer	9.66e-06	0.000193	CcSEcCtD
Gemcitabine—Pruritus—Epirubicin—urinary bladder cancer	9.52e-06	0.00019	CcSEcCtD
Gemcitabine—Diarrhoea—Epirubicin—urinary bladder cancer	9.21e-06	0.000184	CcSEcCtD
Gemcitabine—Vomiting—Methotrexate—urinary bladder cancer	9.14e-06	0.000183	CcSEcCtD
Gemcitabine—Rash—Methotrexate—urinary bladder cancer	9.07e-06	0.000181	CcSEcCtD
Gemcitabine—Dermatitis—Methotrexate—urinary bladder cancer	9.06e-06	0.000181	CcSEcCtD
Gemcitabine—Headache—Methotrexate—urinary bladder cancer	9.01e-06	0.00018	CcSEcCtD
Gemcitabine—Asthenia—Doxorubicin—urinary bladder cancer	8.93e-06	0.000179	CcSEcCtD
Gemcitabine—Pruritus—Doxorubicin—urinary bladder cancer	8.81e-06	0.000176	CcSEcCtD
Gemcitabine—Vomiting—Epirubicin—urinary bladder cancer	8.56e-06	0.000171	CcSEcCtD
Gemcitabine—Nausea—Methotrexate—urinary bladder cancer	8.54e-06	0.000171	CcSEcCtD
Gemcitabine—Diarrhoea—Doxorubicin—urinary bladder cancer	8.52e-06	0.00017	CcSEcCtD
Gemcitabine—Rash—Epirubicin—urinary bladder cancer	8.49e-06	0.00017	CcSEcCtD
Gemcitabine—Dermatitis—Epirubicin—urinary bladder cancer	8.48e-06	0.000169	CcSEcCtD
Gemcitabine—Headache—Epirubicin—urinary bladder cancer	8.43e-06	0.000168	CcSEcCtD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	8.33e-06	0.000192	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	8.32e-06	0.000191	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GSTP1—urinary bladder cancer	8.29e-06	0.000191	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—RRM2—urinary bladder cancer	8.26e-06	0.00019	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	8.26e-06	0.00019	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	8.24e-06	0.00019	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	8.2e-06	0.000189	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—RB1—urinary bladder cancer	8.15e-06	0.000188	CbGpPWpGaD
Gemcitabine—Nausea—Epirubicin—urinary bladder cancer	7.99e-06	0.00016	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	7.98e-06	0.000184	CbGpPWpGaD
Gemcitabine—Vomiting—Doxorubicin—urinary bladder cancer	7.92e-06	0.000158	CcSEcCtD
Gemcitabine—TYMS—Circadian rythm related genes—PTEN—urinary bladder cancer	7.91e-06	0.000182	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	7.86e-06	0.000181	CbGpPWpGaD
Gemcitabine—Rash—Doxorubicin—urinary bladder cancer	7.85e-06	0.000157	CcSEcCtD
Gemcitabine—Dermatitis—Doxorubicin—urinary bladder cancer	7.84e-06	0.000157	CcSEcCtD
Gemcitabine—Headache—Doxorubicin—urinary bladder cancer	7.8e-06	0.000156	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—CCNE1—urinary bladder cancer	7.8e-06	0.00018	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—RRM2—urinary bladder cancer	7.77e-06	0.000179	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—RB1—urinary bladder cancer	7.77e-06	0.000179	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.77e-06	0.000179	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—TYMS—urinary bladder cancer	7.71e-06	0.000177	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ENO2—urinary bladder cancer	7.7e-06	0.000177	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—HPGDS—urinary bladder cancer	7.7e-06	0.000177	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TYMS—urinary bladder cancer	7.66e-06	0.000176	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—HPGDS—urinary bladder cancer	7.65e-06	0.000176	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ENO2—urinary bladder cancer	7.65e-06	0.000176	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	7.64e-06	0.000176	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—NCOR1—urinary bladder cancer	7.62e-06	0.000175	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GSTM1—urinary bladder cancer	7.62e-06	0.000175	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—RB1—urinary bladder cancer	7.59e-06	0.000175	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	7.59e-06	0.000175	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—RB1—urinary bladder cancer	7.55e-06	0.000174	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—EP300—urinary bladder cancer	7.55e-06	0.000174	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—NQO1—urinary bladder cancer	7.54e-06	0.000173	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCNE1—urinary bladder cancer	7.47e-06	0.000172	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTT1—urinary bladder cancer	7.47e-06	0.000172	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	7.47e-06	0.000172	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTT1—urinary bladder cancer	7.42e-06	0.000171	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	7.42e-06	0.000171	CbGpPWpGaD
Gemcitabine—Nausea—Doxorubicin—urinary bladder cancer	7.4e-06	0.000148	CcSEcCtD
Gemcitabine—CDA—Metabolism—GPX1—urinary bladder cancer	7.3e-06	0.000168	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—RB1—urinary bladder cancer	7.29e-06	0.000168	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—HPGDS—urinary bladder cancer	7.2e-06	0.000166	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ENO2—urinary bladder cancer	7.2e-06	0.000166	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	7.17e-06	0.000165	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ERCC2—urinary bladder cancer	7.17e-06	0.000165	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	7.15e-06	0.000165	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	6.99e-06	0.000161	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—TYMP—urinary bladder cancer	6.98e-06	0.000161	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTT1—urinary bladder cancer	6.98e-06	0.000161	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTGS2—urinary bladder cancer	6.96e-06	0.00016	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	6.85e-06	0.000158	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—MTHFR—urinary bladder cancer	6.74e-06	0.000155	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	6.7e-06	0.000154	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	6.7e-06	0.000154	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	6.68e-06	0.000154	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN2A—urinary bladder cancer	6.68e-06	0.000154	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TERT—urinary bladder cancer	6.67e-06	0.000154	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	6.66e-06	0.000153	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN2A—urinary bladder cancer	6.64e-06	0.000153	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	6.61e-06	0.000152	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN2A—urinary bladder cancer	6.41e-06	0.000147	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	6.4e-06	0.000147	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TERT—urinary bladder cancer	6.39e-06	0.000147	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	6.38e-06	0.000147	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	6.33e-06	0.000146	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NAT2—urinary bladder cancer	6.31e-06	0.000145	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	6.31e-06	0.000145	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTP1—urinary bladder cancer	6.29e-06	0.000145	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	6.28e-06	0.000144	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	6.27e-06	0.000144	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—NQO1—urinary bladder cancer	6.21e-06	0.000143	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—NQO1—urinary bladder cancer	6.17e-06	0.000142	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	6.1e-06	0.00014	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTEN—urinary bladder cancer	6.07e-06	0.00014	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	6.07e-06	0.00014	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	6.06e-06	0.000139	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—ATM—urinary bladder cancer	6e-06	0.000138	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDK4—urinary bladder cancer	5.97e-06	0.000138	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	5.87e-06	0.000135	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	5.86e-06	0.000135	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—TYMS—urinary bladder cancer	5.84e-06	0.000135	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—RB1—urinary bladder cancer	5.81e-06	0.000134	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—EP300—urinary bladder cancer	5.81e-06	0.000134	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—NQO1—urinary bladder cancer	5.8e-06	0.000133	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—EP300—urinary bladder cancer	5.79e-06	0.000133	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—NCOR1—urinary bladder cancer	5.78e-06	0.000133	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTM1—urinary bladder cancer	5.78e-06	0.000133	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—EP300—urinary bladder cancer	5.77e-06	0.000133	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—ATM—urinary bladder cancer	5.75e-06	0.000132	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	5.73e-06	0.000132	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDK4—urinary bladder cancer	5.72e-06	0.000132	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	5.67e-06	0.000131	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CCND1—urinary bladder cancer	5.64e-06	0.00013	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	5.62e-06	0.000129	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CCND1—urinary bladder cancer	5.61e-06	0.000129	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—EP300—urinary bladder cancer	5.57e-06	0.000128	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—RB1—urinary bladder cancer	5.57e-06	0.000128	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GPX1—urinary bladder cancer	5.53e-06	0.000127	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	5.49e-06	0.000126	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	5.48e-06	0.000126	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PPARG—urinary bladder cancer	5.46e-06	0.000126	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN1A—urinary bladder cancer	5.46e-06	0.000126	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—RRM2—urinary bladder cancer	5.45e-06	0.000125	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ERCC2—urinary bladder cancer	5.43e-06	0.000125	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN1A—urinary bladder cancer	5.42e-06	0.000125	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CCND1—urinary bladder cancer	5.41e-06	0.000125	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—urinary bladder cancer	5.4e-06	0.000124	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	5.33e-06	0.000123	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CREBBP—urinary bladder cancer	5.25e-06	0.000121	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN1A—urinary bladder cancer	5.24e-06	0.000121	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	5.23e-06	0.00012	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—RB1—urinary bladder cancer	5.19e-06	0.00012	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—EP300—urinary bladder cancer	5.19e-06	0.000119	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTP1—urinary bladder cancer	5.18e-06	0.000119	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—EP300—urinary bladder cancer	5.16e-06	0.000119	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTP1—urinary bladder cancer	5.15e-06	0.000118	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	5.11e-06	0.000118	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—MTHFR—urinary bladder cancer	5.11e-06	0.000118	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MYC—urinary bladder cancer	5.06e-06	0.000116	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—HPGDS—urinary bladder cancer	5.05e-06	0.000116	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ENO2—urinary bladder cancer	5.05e-06	0.000116	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MYC—urinary bladder cancer	5.03e-06	0.000116	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—EP300—urinary bladder cancer	4.98e-06	0.000115	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—RB1—urinary bladder cancer	4.98e-06	0.000115	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTT1—urinary bladder cancer	4.89e-06	0.000113	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	4.89e-06	0.000113	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MYC—urinary bladder cancer	4.86e-06	0.000112	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTP1—urinary bladder cancer	4.84e-06	0.000111	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—TYMS—urinary bladder cancer	4.81e-06	0.000111	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—TYMS—urinary bladder cancer	4.78e-06	0.00011	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—NCOR1—urinary bladder cancer	4.76e-06	0.000109	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTM1—urinary bladder cancer	4.76e-06	0.000109	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—NCOR1—urinary bladder cancer	4.73e-06	0.000109	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTM1—urinary bladder cancer	4.73e-06	0.000109	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	4.64e-06	0.000107	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2A—urinary bladder cancer	4.57e-06	0.000105	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GPX1—urinary bladder cancer	4.56e-06	0.000105	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GPX1—urinary bladder cancer	4.53e-06	0.000104	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MYC—urinary bladder cancer	4.52e-06	0.000104	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—TYMS—urinary bladder cancer	4.5e-06	0.000104	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MYC—urinary bladder cancer	4.5e-06	0.000103	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ERCC2—urinary bladder cancer	4.47e-06	0.000103	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	4.47e-06	0.000103	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ERCC2—urinary bladder cancer	4.45e-06	0.000102	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTM1—urinary bladder cancer	4.45e-06	0.000102	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—NCOR1—urinary bladder cancer	4.45e-06	0.000102	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2A—urinary bladder cancer	4.37e-06	0.000101	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MYC—urinary bladder cancer	4.34e-06	0.0001	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	4.31e-06	9.93e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—urinary bladder cancer	4.3e-06	9.89e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GPX1—urinary bladder cancer	4.26e-06	9.8e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—MTHFR—urinary bladder cancer	4.2e-06	9.68e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ERCC2—urinary bladder cancer	4.18e-06	9.62e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—MTHFR—urinary bladder cancer	4.18e-06	9.62e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	4.17e-06	9.61e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PPARG—urinary bladder cancer	4.14e-06	9.53e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	4.13e-06	9.51e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	4.1e-06	9.43e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	4.08e-06	9.39e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NQO1—urinary bladder cancer	4.07e-06	9.36e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	4.06e-06	9.35e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	4e-06	9.2e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	3.99e-06	9.18e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CREBBP—urinary bladder cancer	3.98e-06	9.15e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—EP300—urinary bladder cancer	3.97e-06	9.14e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—MTHFR—urinary bladder cancer	3.93e-06	9.04e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCND1—urinary bladder cancer	3.86e-06	8.88e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—EP300—urinary bladder cancer	3.8e-06	8.76e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	3.75e-06	8.63e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTEN—urinary bladder cancer	3.75e-06	8.63e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1A—urinary bladder cancer	3.73e-06	8.59e-05	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—urinary bladder cancer	3.72e-06	8.55e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND1—urinary bladder cancer	3.7e-06	8.51e-05	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—urinary bladder cancer	3.69e-06	8.5e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1A—urinary bladder cancer	3.58e-06	8.23e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—EP300—urinary bladder cancer	3.57e-06	8.23e-05	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—urinary bladder cancer	3.57e-06	8.21e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	3.56e-06	8.2e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTO2—urinary bladder cancer	3.55e-06	8.18e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NAT1—urinary bladder cancer	3.55e-06	8.18e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—EP300—urinary bladder cancer	3.55e-06	8.17e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	3.52e-06	8.09e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MYC—urinary bladder cancer	3.46e-06	7.97e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPARG—urinary bladder cancer	3.41e-06	7.85e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—EP300—urinary bladder cancer	3.4e-06	7.83e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTP1—urinary bladder cancer	3.39e-06	7.81e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPARG—urinary bladder cancer	3.39e-06	7.8e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MYC—urinary bladder cancer	3.32e-06	7.63e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CREBBP—urinary bladder cancer	3.28e-06	7.54e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—urinary bladder cancer	3.26e-06	7.5e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CREBBP—urinary bladder cancer	3.26e-06	7.49e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	3.25e-06	7.48e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPARG—urinary bladder cancer	3.19e-06	7.33e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTM1—urinary bladder cancer	3.12e-06	7.17e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NCOR1—urinary bladder cancer	3.12e-06	7.17e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MYC—urinary bladder cancer	3.09e-06	7.12e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CREBBP—urinary bladder cancer	3.06e-06	7.04e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.02e-06	6.95e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GPX1—urinary bladder cancer	2.99e-06	6.87e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	2.98e-06	6.86e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MYC—urinary bladder cancer	2.96e-06	6.82e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ERCC2—urinary bladder cancer	2.93e-06	6.75e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	2.93e-06	6.74e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	2.92e-06	6.71e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTEN—urinary bladder cancer	2.84e-06	6.54e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.76e-06	6.36e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—MTHFR—urinary bladder cancer	2.75e-06	6.34e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—EP300—urinary bladder cancer	2.71e-06	6.23e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.69e-06	6.2e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—urinary bladder cancer	2.68e-06	6.17e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—urinary bladder cancer	2.67e-06	6.14e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.63e-06	6.06e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.55e-06	5.87e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.54e-06	5.85e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—urinary bladder cancer	2.54e-06	5.85e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—urinary bladder cancer	2.51e-06	5.77e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—urinary bladder cancer	2.43e-06	5.6e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.43e-06	5.58e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.36e-06	5.43e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTEN—urinary bladder cancer	2.34e-06	5.38e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTEN—urinary bladder cancer	2.32e-06	5.35e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPARG—urinary bladder cancer	2.23e-06	5.14e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—EP300—urinary bladder cancer	2.23e-06	5.13e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—EP300—urinary bladder cancer	2.22e-06	5.1e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTEN—urinary bladder cancer	2.19e-06	5.03e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.15e-06	4.96e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CREBBP—urinary bladder cancer	2.15e-06	4.94e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.11e-06	4.86e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—EP300—urinary bladder cancer	2.08e-06	4.8e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.07e-06	4.76e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.97e-06	4.53e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.95e-06	4.49e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.95e-06	4.48e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—urinary bladder cancer	1.76e-06	4.04e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.74e-06	3.99e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.68e-06	3.87e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.56e-06	3.58e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.56e-06	3.58e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTEN—urinary bladder cancer	1.53e-06	3.53e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.51e-06	3.48e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—EP300—urinary bladder cancer	1.46e-06	3.36e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.41e-06	3.25e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.25e-06	2.89e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.05e-06	2.41e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TYMS—urinary bladder cancer	9.73e-07	2.24e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	9.62e-07	2.21e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	9.62e-07	2.21e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GPX1—urinary bladder cancer	9.21e-07	2.12e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	9.04e-07	2.08e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	8.5e-07	1.96e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPARG—urinary bladder cancer	6.89e-07	1.59e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	6.62e-07	1.52e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.42e-07	1.25e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTEN—urinary bladder cancer	4.73e-07	1.09e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—EP300—urinary bladder cancer	4.51e-07	1.04e-05	CbGpPWpGaD
